ARTICLE | Company News
Genmab, Medarex, and Glaucus in antibody deal
April 2, 2001 7:00 AM UTC
Glaucus Proteomics (Bunnick, the Netherlands) will develop a set of human antibodies using MEDX's HuMab-Mouse technology for use in an antibody reporter matrix. Glaucus will use the matrix in healthy ...